The chart below shows how BHE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BHE sees a -1.06% change in stock price 10 days leading up to the earnings, and a +5.75% change 10 days following the report. On the earnings day itself, the stock moves by -0.48%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Performance: 4th quarter revenue of $657,000,000 was in line with guidance, with semi cap revenue increasing 18% year over year and A&D revenue up 20%.
Gross Margin Improvement: Non GAAP gross margin in Q4 was 10.4%, representing a 10 basis point increase year over year, and full year non GAAP gross margin increased by 70 basis points to 10.2%.
Strong Free Cash Flow: Free cash flow generation for the fiscal year 2024 was over $156,000,000, demonstrating strong cash management despite revenue declines.
Inventory Reduction Impact: Inventory was reduced by over $130,000,000 or 20% during the year, contributing to improved working capital efficiency.
Dividend Payments Overview: Cash dividends paid in the quarter totaled $6,100,000, with a total of $23,900,000 paid during fiscal year 2024, reflecting a commitment to returning capital to shareholders.
Negative
Medical Revenue Decline: Medical revenue was down 19% versus the prior year due to inventory rebalancing and end demand weakness within medical devices.
Revenue Decline Analysis: AC and C revenue decreased 48% year over year, driven by the completion of large HPC programs and continued weakness in the communications business.
Revenue Decline Analysis: Fiscal year 2024 revenue of $2,700,000,000 was down over the prior year by 6%.
Operating Margin Decline: Non GAAP operating margin was 5.1%, down 20 basis points sequentially and down 40 basis points year over year due to higher variable compensation expense.
Liquidity Ratio Decline: The Q4 liquidity ratio was 0.6, down from 1.1 in the prior year period, indicating a decline in financial health.
Earnings call transcript: Benchmark Electronics Q4 2024 beats EPS forecast
BHE.N
0.91%